HER2-amplified cells demonstrated an intermediary oxidative profile when compared to the other BC cells investigated at basal levels, potentially because HER2 overexpression attenuates OS in breast cancer [32,49]. This evidence concerns the gene ERBB2 and breast carcinoma.